Gene Biotherapeutics, Inc.
Gene Biotherapeutics, Inc. (CRXM) is a publicly traded company in the Unknown sector. Across all available filings, 1 corporate insiders have executed 2 transactions totaling $92.0K, demonstrating a bullish sentiment with $92.0K in net insider flow. The most recent transaction on Mar 17, 2021 involved a purchase of 200,000 shares valued at $80.0K.
CRXM Recent Transactions
2 transactionsDate | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 17, 2021 | J. Jemapete Christopher | Executive | Purchase | 200,000 | $0.40 | $80.0K | |
| Mar 16, 2021 | J. Jemapete Christopher | Executive | Purchase | 300,000 | $0.04 | $12.0K |
CRXM Insider Activity Summary
Who Is Buying CRXM Stock?
No significant insider buying has been recorded for CRXM in the recent period.
Who Is Selling CRXM Stock?
No significant insider selling has been recorded for CRXM in the recent period.
Is Gene Biotherapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CRXM is bullish with an Insider Alignment Score of 100/100 and a net flow of $92.0K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
CRXM Frequently Asked Questions
Understanding CRXM Insider Activity
Insider trading at Gene Biotherapeutics, Inc. (CRXM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 1 insiders are actively trading CRXM stock, having executed 2 transactions in the past 90 days. The most active insider is Christopher J. Jemapete (Executive), who has made 2 transactions totaling $92.0K.
Related Tools
Track Gene Biotherapeutics, Inc. Insider Activity
Get notified when executives and directors at CRXM file new Form 4 transactions